Skip to content

The Beilhack Lab

Novel Concepts for Immunotherapy

  • Startseite
  • Research
  • Team
  • Publications
  • Careers
  • Research Networks
  • Funding
  • News
  • Contact
The Beilhack Lab

Blocking_GDF-15_Enhancing_Cancer_Immunotherapy_

26. June 2024 beilhack

Breakthrough in overcoming immune therapy rresistance. Blocking GDF-15 enables tumor-specific immune cells to overcome a road-block for attacking cancer cells. Würzburg University Hospital, Germany. Beilhack lab advancing immunotherapy

Archives

Recent Posts

  • Dr. Haroon Shaikh Wins Prestigious EBMT Basic Science Award 2024 for Breakthrough in Graft-Versus-Host Disease Research
  • Innovative antibody design targets TNFR2 for safer, more effective treatments
  • Decoding Two-Way Brain-Gut Communication Unveils New Insights into Neurological Diseases
  • Dr. Stefanie Schwinn Awarded Top Thesis Award
  • Breakthrough in Overcoming Immune Therapy Resistance
  • Linoleic Acid Unleashes Potent Antitumor Immunity in CD8+ T Cells
  • New study identifies niches that sustain Tregs
  • How tissue-specific unconventional T cells shape local immune responses
  • Laufend gegen Krebs – Würzburg City Marathon
  • JAM-C as a switch for multiple myeloma dissemination
Impressum